Stephen I. Sadove - May 3, 2023 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Role
Director
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
Stock symbol
CL
Transactions as of
May 3, 2023
Transactions value $
-$177,741
Form type
4
Date filed
5/5/2023, 04:25 PM
Previous filing
Apr 28, 2023
Next filing
May 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CL Common Stock Options Exercise $393K +6.33K +53.34% $62.04 18.2K May 3, 2023 Direct F1
transaction CL Common Stock Options Exercise $409K +5.7K +31.34% $71.65 23.9K May 3, 2023 Direct F1
transaction CL Common Stock Sale -$979K -12K -50.35% $81.37 11.9K May 3, 2023 Direct F2, F3
holding CL Common Stock 13K May 3, 2023 By Family Trust
holding CL Common Stock 9.22K May 3, 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CL Stock Option (Right to Buy) Options Exercise $0 -6.33K -100% $0.00* 0 May 3, 2023 Common Stock 6.33K $62.04 Direct F1, F4
transaction CL Stock Option (Right to Buy) Options Exercise $0 -5.7K -100% $0.00* 0 May 3, 2023 Common Stock 5.7K $71.65 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of stock options awarded under the issuer's incentive compensation plan.
F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.
F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $81.2410 to $81.7100, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Option became exercisable in one-third increments beginning on the first anniversary of the May 14, 2018 grant date.
F5 Option became exercisable in one-third increments beginning on the first anniversary of the May 15, 2017 grant date.